Pulse methylprednisolone therapy for the treatment of extensive alopecia areata

Journal of Dermatological Treatment

Volumn 25, Issue 2, 2014, Pages 164-166

  Açikgöz, Gürol ^a   Özmen, Ibrahim ^b   Çayirli, Mutlu ^c   Yeniay, Yildiray ^a   Köse, Osman ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Tekirdag   (Turkey)

^c Agri Military Hospital   (Turkey)

Author keywords

Alopecia totalis; Alopecia universalis; Prednisolone

Indexed keywords

METHYLPREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA; ALOPECIA AREATA; ALOPECIA TOTALIS; ALOPECIA UNIVERSALIS; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DRUG PULSE THERAPY; DRUG TOLERABILITY; HAIR GROWTH; HAIR LOSS; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCALP HAIR; TREATMENT RESPONSE;

ADMINISTRATION, INTRAVENOUS; ADULT; ALOPECIA AREATA; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890389078     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2013.768759     Document Type: Article

References (16)

1. Paus R, Olsen EA, Messenger AG. Hair growth disorders. In Wolff K, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 7th ed. McGraw-Hill, 2008. p 762-765.
2. Winter RJ, Kern F, Blizzard RM. Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol. 1976;112:1549-1552.
3. Burton JL, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol. 1975;55:493-496.
4. Kurosawa M, Nakagawa S, Mizuashi M, et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology. 2006; 212:361-365.
5. Kountz SL, Cohn R. Initial treatment of renal allografts with large intrarenal doses of immunosuppressive drugs. Lancet. 1969;1: 338-340.
6. Bell PR, Briggs JD, Calman KC, et al. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet. 1971;1:876-880.
7. Perriard-Wolfensberger J, Pasche-Koo F, Mainetti C, et al. Pulse of methylprednisolone in alopecia areata. Dermatology. 1993;187: 282-285.
8. Kiesch N, Stene JJ, Goens J, et al. Pulse steroid therapy for children's severe alopecia areata? Dermatology. 1997;194:395-397.
9. Friedli A, Labarthe MP, Engelhardt E, et al. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol. 1998;39:597-602.
10. Seiter S, Ugurel S, Tilgen W, et al. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology. 2001; 202:230-234.
11. Tsai YM, Chen W, Hsu ML, et al. High-dose steroid pulse therapy for the treatment of severe alopecia areata. J Formos Med Assoc. 2002;101: 223-226.
12. Assouly P, Reygagne P, Jouanique C, et al. Intravenous pulse methylprednisolone therapy for severe alopecia areata: An open study of 66 patients. Ann Dermatol Venereol. 2003;130:326-330.
13. Luggen P, Hunziker T. High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature. J Dtsch Dermatol Ges. 2008;6:375-378.
14. Im M, Lee SS, Lee Y, et al. Prognostic factors in methylprednisolone pulse therapy for alopecia areata. J Dermatol. 2011;38:767-772.
15. Shaheedi-Dadras M, Karami A, Mollaei F, et al. The effect of methylprednisolone pulse-Therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med. 2008; 11:90-93.
16. Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: Study of 139 patients. Dermatology. 2007;215:320-324.